MX2015006797A - Vacuna para proteger un rumiante contra la neumonia causada por pasteurella multocida. - Google Patents
Vacuna para proteger un rumiante contra la neumonia causada por pasteurella multocida.Info
- Publication number
- MX2015006797A MX2015006797A MX2015006797A MX2015006797A MX2015006797A MX 2015006797 A MX2015006797 A MX 2015006797A MX 2015006797 A MX2015006797 A MX 2015006797A MX 2015006797 A MX2015006797 A MX 2015006797A MX 2015006797 A MX2015006797 A MX 2015006797A
- Authority
- MX
- Mexico
- Prior art keywords
- vaccine
- protect
- pneumonia caused
- ruminant
- against pneumonia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una vacuna que comprende la bacteria Pasteurella multocida viva atenuada, para la protección de un rumiante contra la neumonía causada por P. multocida por medio de la administración de la vacuna en el tracto respiratorio superior del rumiante por atomización intranasal de la vacuna; la invención también se refiere a un método para usar la vacuna para proteger a un rumiante contra la neumonía causada por la bacteria P. multocida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12194759 | 2012-11-29 | ||
PCT/EP2013/074930 WO2014083091A1 (en) | 2012-11-29 | 2013-11-28 | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015006797A true MX2015006797A (es) | 2015-09-10 |
MX356560B MX356560B (es) | 2018-06-04 |
Family
ID=47226059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015006797A MX356560B (es) | 2012-11-29 | 2013-11-28 | Vacuna para proteger a un rumiante contra la neumonia causada por pasteurella multocida. |
Country Status (9)
Country | Link |
---|---|
US (2) | US20140147475A1 (es) |
EP (1) | EP2925354B1 (es) |
AU (1) | AU2013351213B2 (es) |
BR (1) | BR112015012274A2 (es) |
ES (1) | ES2676833T3 (es) |
MX (1) | MX356560B (es) |
RU (1) | RU2613672C2 (es) |
WO (1) | WO2014083091A1 (es) |
ZA (1) | ZA201503804B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140147475A1 (en) | 2012-11-29 | 2014-05-29 | Antonius Arnoldus Christiaan Jacobs | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
BR112015023870A2 (pt) | 2013-03-18 | 2017-07-18 | Intervet Int Bv | vacina, uso de bactérias atenuadas vivas, método para proteger um ruminante contra pneumonia, e, bactérias atenuadas vivas |
US9757445B2 (en) | 2013-11-01 | 2017-09-12 | Merial Inc. | Attenuated Pasteurella multocida vaccines and methods of making and use thereof |
CN113046271B (zh) * | 2021-04-10 | 2022-10-14 | 福建省农业科学院畜牧兽医研究所 | 一株兔f型多杀性巴氏杆菌及其在制备灭活疫苗中的应用 |
CN113855793A (zh) * | 2021-10-19 | 2021-12-31 | 西南大学 | 牛源a型多杀性巴氏杆菌基因缺失株的应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4132775A (en) | 1973-12-03 | 1979-01-02 | Richardson-Merrell Inc. | Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same |
US5256415A (en) | 1989-03-20 | 1993-10-26 | Louisiana State University | Vaccine against bovine respiratory disease (pasteurellosis) |
EP0650734B1 (en) | 1993-10-28 | 1999-03-10 | Division Of Microbiology, Kyoto Biken Laboratories, Inc. | Pentavalent live viral vaccine |
EP0810283A3 (en) | 1996-05-31 | 1997-12-10 | Akzo Nobel N.V. | Live attenuated RTX-procucing bacteria of the family Pasteurellaceae |
FI20002217A (fi) | 1999-12-30 | 2001-07-01 | Orion Yhtymae Oyj | Inhalaatiopartikkelit |
US7923023B2 (en) | 2002-02-25 | 2011-04-12 | Astech International LLC | Method and composition for delivery of medicants to animals |
US7217420B2 (en) | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
AU2003263390B2 (en) | 2002-08-26 | 2008-12-18 | Zoetis Services Llc | Vaccine for respiratory and reproductive system infections in cattle |
US6830010B2 (en) * | 2002-10-22 | 2004-12-14 | Heartland Premium Beef, Inc. | Quality assurance program and method for meat production |
NZ543771A (en) * | 2003-07-02 | 2008-05-30 | Biotechnology Res & Dev | Acapsular Pasteurella multocida hyae deletion mutants |
FR2862306B1 (fr) * | 2003-11-17 | 2008-05-30 | Aventis Pasteur | Composition vaccinale |
WO2005077409A1 (en) | 2004-02-18 | 2005-08-25 | The University Of Newcastle Research Associates Limited | A vaccine formulated for administration to mucosa of the lungs |
CA2591624A1 (en) * | 2004-12-22 | 2006-11-23 | Intervet International B.V. | Pasteurella multocida vaccine |
US20080241192A1 (en) | 2007-03-26 | 2008-10-02 | Wyeth | Vaccination against multiple serotypes of pasteurella multocida |
US20140147475A1 (en) | 2012-11-29 | 2014-05-29 | Antonius Arnoldus Christiaan Jacobs | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
BR112015023870A2 (pt) | 2013-03-18 | 2017-07-18 | Intervet Int Bv | vacina, uso de bactérias atenuadas vivas, método para proteger um ruminante contra pneumonia, e, bactérias atenuadas vivas |
-
2013
- 2013-11-26 US US14/090,178 patent/US20140147475A1/en not_active Abandoned
- 2013-11-28 BR BR112015012274A patent/BR112015012274A2/pt not_active Application Discontinuation
- 2013-11-28 MX MX2015006797A patent/MX356560B/es active IP Right Grant
- 2013-11-28 AU AU2013351213A patent/AU2013351213B2/en active Active
- 2013-11-28 ES ES13795795.7T patent/ES2676833T3/es active Active
- 2013-11-28 US US14/647,337 patent/US9662382B2/en active Active
- 2013-11-28 WO PCT/EP2013/074930 patent/WO2014083091A1/en active Application Filing
- 2013-11-28 EP EP13795795.7A patent/EP2925354B1/en active Active
- 2013-11-28 RU RU2015125313A patent/RU2613672C2/ru not_active IP Right Cessation
-
2015
- 2015-05-27 ZA ZA2015/03804A patent/ZA201503804B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20140147475A1 (en) | 2014-05-29 |
US9662382B2 (en) | 2017-05-30 |
RU2015125313A (ru) | 2017-01-11 |
WO2014083091A1 (en) | 2014-06-05 |
EP2925354A1 (en) | 2015-10-07 |
MX356560B (es) | 2018-06-04 |
ES2676833T3 (es) | 2018-07-25 |
US20150297704A1 (en) | 2015-10-22 |
RU2613672C2 (ru) | 2017-03-21 |
EP2925354B1 (en) | 2018-06-06 |
BR112015012274A2 (pt) | 2017-07-11 |
AU2013351213A1 (en) | 2015-05-21 |
AU2013351213B2 (en) | 2017-10-19 |
ZA201503804B (en) | 2019-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2541301B (en) | Respiratory gas humidification system | |
NZ739760A (en) | Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same | |
NZ704584A (en) | Liquid stable virus vaccines | |
DK3284459T3 (en) | Pharmaceutical compositions comprising a local anaesthetic such as Bupivacaine for local administration to the mouth or throat | |
MY168300A (en) | Pharmaceutical Composition for Inhalation | |
MX356560B (es) | Vacuna para proteger a un rumiante contra la neumonia causada por pasteurella multocida. | |
HK1221654A1 (zh) | 用於呼吸遞送三種或更多種活性劑的組合物、方法和系統 | |
HUE055409T2 (hu) | Vakcinázási összeállítás vakcina jércemadarakhoz való továbbítására | |
MX2015011894A (es) | Composiciones farmaceuticas para administracion rectal. | |
PL2996549T3 (pl) | Kierowany układ do intubacji dotchawicznej | |
IN2014DN06964A (es) | ||
IL234937A0 (en) | Improved booster system for oral administration of vaccine | |
MX2015013307A (es) | Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica. | |
HK1202026A1 (en) | Acidic aqueous compositions for elimination of spores of spore forming bacteria | |
IN2013CH04314A (es) | ||
IN2013MU02279A (es) | ||
IN2013MU02595A (es) | ||
MX366763B (es) | Composiciones farmacéuticas de montelukast y levocetirizina. | |
WO2013175347A3 (en) | Compositions and methods for treatment of respiratory disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |